Poloxamer P188 Protects Against Heart Damage in Mice Lacking Dystrophin
Author Information
Author(s): Christopher F Spurney, Alfredo D Guerron, Qing Yu, Arpana Sali, Jack H van der Meulen, Eric P Hoffman, Kanneboyina Nagaraju
Primary Institution: Children's National Medical Center
Hypothesis
Chronic treatment with Poloxamer P188 can prevent cardiomyopathy induced by isoproterenol in dystrophin-deficient mice.
Conclusion
Chronic intermittent treatment with Poloxamer P188 can prevent heart damage in dystrophin-deficient mice exposed to isoproterenol.
Supporting Evidence
- Mdx mice treated with P188 showed improved heart rates compared to untreated mice.
- P188 treatment prevented a decrease in cardiac function in isoproterenol exposed mice.
- Significant differences in cardiac fibrosis were not observed between treated and untreated groups.
Takeaway
This study shows that a special treatment can help protect the hearts of mice that have a muscle disease, making their hearts work better even when stressed.
Methodology
Mice were treated with Poloxamer P188 and exposed to isoproterenol, with cardiac function assessed using echocardiography.
Potential Biases
Potential bias in treatment administration and measurement of outcomes.
Limitations
The study was limited to a specific mouse model and may not fully translate to human conditions.
Participant Demographics
Three-month-old female mdx mice were used in the study.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website